COMPANY PROFILE

Seed Health

Explore full profile

Microbial sciences company pioneering applications of bacteria to impact human and environmental health

Los Angeles, United StatesFounded 2016Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2021

Headcount 100–500 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Seed Health

Seed Health operates in the microbial sciences sector, focusing on the development and commercialization of consumer products that leverage the benefits of microbes to improve human and planetary health. The company serves health-conscious consumers interested in probiotics and microbiome-related products. Seed Health's business model revolves around direct-to-consumer sales through its e-commerce platform, where it offers scientifically-backed products designed to enhance overall well-being. Revenue is generated primarily through the sale of these products, which include probiotics for humans and pets. The company emphasizes rigorous scientific research and innovation, ensuring that its products are both effective and safe. Seed Health also engages in educational initiatives to raise awareness about the importance of microbial health, using creative marketing strategies to make science accessible and engaging. Keywords: microbial sciences, probiotics, human health, planetary health, e-commerce, direct-to-consumer, innovation, research, education, microbiome.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Los Angeles, United States
Employees: 253
Open positions: None listed
Dealroom signal: 80.2/100
Industry: Health
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, Research and Development, Bacteria, Microbiology, Microbiome, Probiotics, Biotech and Pharma, Hard Tech, AI Applications
Technology: Artificial Intelligence
Client focus: b2b
Investment activity: 2 companies, latest Feb 2021
Capital deployed: $2.8M
Preferred round: ACQUISITION
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Seed Health.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES A✓Equity / VC	Apr 2021	$40M	$160M	Artis Ventures · GISEV Family Office · Founders Fund · 8VC	—
OtherOther financing	Mar 2019	$0	—	Alumni Ventures · Greycroft Partners	—

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Seed Health website traffic

Latest recorded traffic for Seed Health is 1.2M monthly website visits, up 0% over the last three months. Seed Health's team grew 4.1% over the past year.

Latest monthly visits1.2M 3-month web change0% 1-year team growth+4.1%

Monthly website visitsApr 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
JOJonaUsing AI technology to analyze and interpret an individual's microbiome, providing actionable insights and recommendations to improve their health and prevent chronic diseases	New York City, United States	Operational	34	$7.1M	$23M
HOHolloidProvides real-time multi-dimensional data on colloids, based on 3D imaging, with the throughput of cytometry	Vienna, Austria	Operational
KAKariusFocused on conquering infectious diseases through the use of genomics to analyze microbial cell-free DNA	Redwood City, United States	Operational
AIAirBiometricsHelps to regain sovereignty over well-being	Castellón de la Plana, Spain	Operational
NENeurox1Target ID and drug discovery platform for neurological diseases	Austin, United States	Operational
OMOmicsChartPatient-centric cancer data and analytics platform for translational cancer biologists	Cardiff, United Kingdom	Operational
BRBrainify.AIBrainify.AI is an AI/ML electroencephalography (EEG) biomarker platform for novel treatment development aimed at depression that increases the likelihood of new drug approval by 80% and reduces R&D costs by $1.5B	New York City, United States	Operational
SESelfDecodeA health optimization app that is based on an individual's dna	Miami, United States	Operational